0.23Open0.23Pre Close1.85K Volume1.14K Open Interest84.00Strike Price90.16KTurnover1235.79%IV1.90%PremiumAug 23, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0310Delta0.0842Gamma8244.00Leverage Ratio-111.8805Theta0.0000Rho255.82Eff Leverage0.0000Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.